Results 31 to 40 of about 77,862 (256)

Risk of Abnormal Uterine Bleeding in Women with Chronic Spontaneous Urticaria: Korean Nationwide Population-Based Cohort. [PDF]

J Clin Med
Park SY, Kim JY, Song JE.
europepmc   +2 more sources

Chronic inducible urticaria: confirmation through challenge tests and response to treatment

Einstein (São Paulo), 2020
Objective To evaluate the positivity of challenge tests of patients suspected of chronic inducible urticaria and the response to treatment. Methods A retrospective study of electronic medical records of patients suspected of chronic inducible ...
Amanda Rocha Firmino Pereira, Antônio Abílio Motta, Jorge Kalil, Rosana Câmara Agondi   +3 more
doaj   +2 more sources

Brain Injury Associated with Chronic Spontaneous Urticaria: a Kounis-Like Syndrome?

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2020
‘Kounis Syndrome’ is an acute coronary artery event due to an artery spasm occurring during immediate hypersensi- tivity reactions or chronic spontaneous urticaria. Recently it has been reported in other systems, including the cerebral vasculature.
Luis Santiago, Margarida Gonçalo
doaj   +1 more source

Epidemiologic features in patients with antihistamine-resistant chronic urticaria

Revista Alergia México, 2015
Background: Current information on the particular features of patients suffering chronic spontaneous urticaria refractory to treatment is limited.  Objective: To investigate demographic and clinical characteristics in patients with refractory chronic ...
Mario Sánchez-Borges, Stefano Tassinari, Adriana Flores   +2 more
doaj   +1 more source

Remibrutinib (Rhapsido) for chronic spontaneous urticaria. [PDF]

Trends Pharmacol Sci
The FDA has approved remibrutinib (Rhapsido – Novartis), an oral Bruton's tyrosine kinase (BTK) inhibitor, for treatment of chronic spontaneous urticaria in adults who remain symptomatic despite H1-antihistamine treatment. Remibrutinib is the first oral drug to be approved in the US for this indication.
Lamkin EN, Bravo E, Taylor J.
europepmc   +3 more sources

Targeted Therapy for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Critical Narrative Review and an Evidence-Graded Approach to Agent Selection. [PDF]

Antibodies (Basel)
Guarino L, Rizzuto G, Coppolelli V, Scipione A, Scattone M, Gargano L, Scribani Rossi P, Del Duca E, Dattola A, Pellacani G, Nisticò S, Chello C.   +11 more
europepmc   +2 more sources

Ligelizumab for Chronic Spontaneous Urticaria

New England Journal of Medicine, 2019
In the majority of patients with chronic spontaneous urticaria, most currently available therapies do not result in complete symptom control. Ligelizumab is a next-generation high-affinity humanized monoclonal anti-IgE antibody. Data are limited regarding the dose-response relationship of ligelizumab and the efficacy and safety of ligelizumab as ...
Marcus Maurer, Ana M. Giménez-Arnau, Gordon Sussman, Martin Metz, Diane R. Baker, Andrea Bauer, Jonathan A. Bernstein, Randolf Brehler, Chia-Yu Chu, Wen-Hung Chung, Inna Danilycheva, Clive Grattan, Jacques Hébert, Constance Katelaris, Michael Makris, Raisa Meshkova, Sinisa Savic, Rodney Sinclair, Karl Sitz, Petra Staubach, Bettina Wedi, Jürgen Löffler, Avantika Barve, Kenneth Kobayashi, Eva Hua, Thomas Severin, Reinhold Janocha   +26 more
openaire   +4 more sources

Urticaria and mimickers of urticaria

Frontiers in Allergy, 2023
Urticaria is a common skin condition encountered across various specialties in medicine, especially in dermatology and allergy/immunology practice. It has a heterogeneous presentation hence it is unsurprising that many skin conditions may be confused ...
Jie Shen Fok, Jie Shen Fok, Jie Shen Fok, Constance H. Katelaris, Constance H. Katelaris   +4 more
doaj   +1 more source

The many faces of pediatric urticaria

Frontiers in Allergy, 2023
Urticaria is a common disease that can affect individuals of all age groups, with approximately one-quarter of the population experiencing it at least once in their lifetime.
Bulent Enis Sekerel, Deniz Ilgun Gurel, Umit Murat Sahiner, Ozge Soyer, Emek Kocaturk   +4 more
doaj   +1 more source

Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies

Case Reports in Medicine, 2015
Chronic spontaneous urticaria is an itching skin disease characterised by wheals, angioedema, or both present for more than six weeks. Omalizumab is a humanized anti-IgE monoclonal antibody recently approved for treatment of chronic urticaria.
Misbah Nasheela Ghazanfar, Simon Francis Thomsen   +1 more
doaj   +1 more source